BRAF and neoplasm: It has been reported that a large majority (43–87%) of MSI-H sporadic tumours have BRAF mutations, whereas only a small proportion (4–9%) of MSS tumours have BRAF mutations (Domingo et al, 2004; Kambara et al, 2004).